Concepedia

Masayuki Kanki

MK

Statistics

Publications

9

Citations

314

H-Index

9

Active since

2007

Affiliations

Astellas Pharma (Japan)(Current)

Takeda (Japan)

National Institute of Health Sciences

National Institute of Biomedical Innovation, Health and Nutrition

Doshisha Women's College of Liberal Arts

Masayuki Kanki is an author at Astellas Pharma (Japan) specializing in toxicology, microrna biology, and microrna biomarkers.

Publications per year

2007–2023

9

Publications

9

Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats

Masako Muguruma, Akira Unami, Masayuki Kanki et al. · Toxicology · 2007 · 82 citations

, , +16

Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats

Masayuki Kanki, Akira Moriguchi, Daisuke Sasaki et al. · Toxicology · 2014 · 80 citations

, , +8

miRNA expression atlas in male rat

Keiichi Minami, Takeki Uehara, Yuji Morikawa et al. · Scientific Data · 2014 · 60 citations · Full text

, , +13

MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease

Ayano Takeuchi-Yorimoto, Yu Yamaura, Masayuki Kanki et al. · Toxicology Letters · 2016 · 30 citations

, , +16

Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats

Ko Omura, Takeki Uehara, Yuji Morikawa et al. · The Journal of Toxicological Sciences · 2014 · 16 citations · Full text

, , +17

1–5 of 9